Blueblood Ventures Ltd
Incorporated in 2007, Blueblood Ventures
Ltd provides investment and trading in the financial market[1]
- Market Cap ₹ 3.32 Cr.
- Current Price ₹ 11.1
- High / Low ₹ /
- Stock P/E 19.5
- Book Value ₹ 50.8
- Dividend Yield 0.00 %
- ROCE 3.56 %
- ROE 1.12 %
- Face Value ₹ 10.0
Pros
- Stock is trading at 0.22 times its book value
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Company has low interest coverage ratio.
- Company might be capitalizing the interest cost
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Financial Services Financial Services Finance Other Financial Services
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
| Operating Profit |
| OPM % |
| Interest |
| Depreciation |
| Profit before tax |
| Tax % |
| EPS in Rs |
| Raw PDF |
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2016 | Mar 2017 | |
|---|---|---|
| 0.72 | 2.73 | |
| -10.13 | -1.67 | |
| Operating Profit | 10.85 | 4.40 |
| OPM % | 1,506.94% | 161.17% |
| 0.00 | 0.00 | |
| Interest | 10.63 | 4.11 |
| Depreciation | 0.04 | 0.03 |
| Profit before tax | 0.18 | 0.26 |
| Tax % | 27.78% | 34.62% |
| 0.12 | 0.17 | |
| EPS in Rs | 0.40 | 0.57 |
| Dividend Payout % | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 279% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 42% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | -6% |
| 5 Years: | 4% |
| 3 Years: | 0% |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | 1% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2016 | Mar 2017 | |
|---|---|---|
| Equity Capital | 3.00 | 3.00 |
| Reserves | 12.10 | 12.23 |
| 100.20 | 114.77 | |
| 22.28 | 28.23 | |
| Total Liabilities | 137.58 | 158.23 |
| 0.08 | 0.07 | |
| CWIP | 0.00 | 0.00 |
| Investments | 0.13 | 5.78 |
| 137.37 | 152.38 | |
| Total Assets | 137.58 | 158.23 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2016 | Mar 2017 | |
|---|---|---|
| -59.78 | -5.00 | |
| 0.01 | -5.52 | |
| 59.38 | 10.44 | |
| Net Cash Flow | -0.39 | -0.07 |
| Free Cash Flow | -59.78 | -5.02 |
| CFO/OP | -550% | -109% |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2016 | Mar 2017 | |
|---|---|---|
| Debtor Days | 0.00 | 0.00 |
| Inventory Days | ||
| Days Payable | ||
| Cash Conversion Cycle | 0.00 | 0.00 |
| Working Capital Days | 58,258.06 | 16,586.78 |
| ROCE % | 3.56% |
Insights
In beta| Mar 2013 | Mar 2014 | Mar 2015 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|---|---|---|---|
| Inventory (Stock-in-trade) INR Lakhs ・Standalone data |
|
||||||||
| Non-current Investments INR Lakhs ・Standalone data |
|||||||||
| Number of Employees Count ・Standalone data |
|||||||||
| Number of Shareholders Count ・Standalone data |
|||||||||
Extracted by Screener AI
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Meeting Updates
27 May - Blueblood approved FY26 audited standalone results on 27 May 2026; profit Rs 3.26 lakh, unmodified audit opinion.
-
Board Meeting Outcome for Board Meeting Outcome For Board Meeting Outcome For The Board Has Decided To Approve Standalone Annual Audited Financial Results For The Financial Year 2025-2026 Along With Auditors Report Thereon
27 May - Board approved FY26 standalone audited results on 27 May 2026; auditor gave unmodified opinion.
- Closure of Trading Window 15 May
-
Board Meeting Intimation for Board Meeting Intimation For Board Meeting Intimation For :-To Approve Audited Standalone Financials Results Of The Company For The Half And Financial Year Ended 31 St March,2026.
15 May - Board meeting on 27 May 2026 to approve audited standalone results for half year and year ended 31 March 2026.
-
Declaration Under Regulation 31(4) Of SEBI (Substantial Acquisition Of Shares Andtakeovers) Regulation, 2011.
8 Apr - Promoters and PAC confirmed nil pledged or encumbered shares as of 31 March 2026.
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
Business Overview:[1]
BBL is in the business of equity investment and trading in equity, derivatives, commodities, futures & options, venture capital funding, and other financial products.